Trial Profile
Phase I/II trial of thioureidobutyronitrile (Kevetrin)+ cytarabine in patients with acute myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 29 Sep 2014
Price :
$35
*
At a glance
- Drugs Thioureidobutyronitrile (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Innovation Pharmaceuticals
- 24 Sep 2014 The protocol for this trial has been submitted to the ethics committee, according to a Cellceutix media release. This trial is expected to start in quarter 4, 2014.
- 09 Dec 2013 New trial record